Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Theratechnologies Inc T.TH

Alternate Symbol(s):  THTX

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs... see more

TSX:TH - Post Discussion

Theratechnologies Inc > Example of transparency
View:
Post by palinc2000 on Mar 26, 2022 9:25am

Example of transparency

I recently purchased stock in this company after the CEO made a lclise to 1 million dollar purchase.I bought almost solely on that ..... this morning I am doing my DD on the stock before adding to my small position
I am impressed by the transparency in the historical investor presentations ..Past  presentations are all available and easily accessible .... and mostly easily comparable to see what has changed!!!!
This also means that management own everything they say and not trying to hide 
https://www.canaccordgenuity.com/investor-relations/news-and-events/investor-presentations/
Comment by SPCEO1 on Mar 26, 2022 11:44am
Palinc2000 - maybe you can use your influence as a shareholder of Canaccord Genuity to get their research team to assign their cancer drug analyst to the stock now! I suggest you draw up a shareholder resolution immediately as Ed Nash, CG's NASH analyst, is now just mailing it it with his coverage of TH. Ed is a good guy and a good analyst who hung on for a long time doing a decent job on TH ...more  
Comment by palinc2000 on Mar 26, 2022 2:12pm
Maybe they are waiting for Paul to do what he should have done soon after his nomination to compensate for his weakness in financial matters 
Comment by Momo25 on Mar 26, 2022 4:19pm
Bad analyst coverage! A new slogan as a cover up for a failing company. What would a good boy analyst will do to bring the attention of the stock market when we have a phase 1a of 14 month elapse time with 0 outcome up to now. Instead of trying to justify the failure of the company and the incompetency of it's board, please try at least to be honest.
Comment by ANALIAS00 on Mar 27, 2022 9:12am
I would expect the for all cie. It shows respect to shareholders .
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities